Prelude Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-125,029
| Closed | -$8.51M | – | 1820 |
|
|
2022
Q3 | $8.51M | Buy |
+125,029
| New | +$8.51M | 0.31% | 44 |
|
|
2020
Q4 | – | Sell |
-7,705
| Closed | -$425K | – | 1758 |
|
|
2020
Q3 | $425K | Buy |
7,705
+1,855
| +32% | +$102K | 0.02% | 320 |
|
|
2020
Q2 | $369K | Buy |
+5,850
| New | +$369K | 0.02% | 356 |
|
|
2020
Q1 | – | Sell |
-138
| Closed | -$11K | – | 1736 |
|
|
2019
Q4 | $11K | Buy |
138
+15
| +12% | +$1.2K | ﹤0.01% | 1232 |
|
|
2019
Q3 | $6K | Sell |
123
-18,033
| -99% | -$880K | ﹤0.01% | 1066 |
|
|
2019
Q2 | $955K | Buy |
18,156
+7,708
| +74% | +$405K | 0.05% | 184 |
|
|
2019
Q1 | $553K | Buy |
+10,448
| New | +$553K | 0.03% | 269 |
|
|
2018
Q4 | – | Sell |
-57,446
| Closed | -$2.18M | – | 1851 |
|
|
2018
Q3 | $2.18M | Buy |
57,446
+8,283
| +17% | +$315K | 0.13% | 115 |
|
|
2018
Q2 | $2.22M | Buy |
49,163
+20,784
| +73% | +$939K | 0.14% | 105 |
|
|
2018
Q1 | $1.37M | Buy |
28,379
+26,183
| +1,192% | +$1.26M | 0.1% | 171 |
|
|
2017
Q4 | $86K | Sell |
2,196
-5,397
| -71% | -$211K | 0.01% | 728 |
|
|
2017
Q3 | $236K | Buy |
7,593
+2,593
| +52% | +$80.6K | 0.02% | 531 |
|
|
2017
Q2 | $137K | Buy |
5,000
+800
| +19% | +$21.9K | 0.01% | 630 |
|
|
2017
Q1 | $155K | Sell |
4,200
-300
| -7% | -$11.1K | 0.01% | 606 |
|
|
2016
Q4 | $65K | Sell |
4,500
-1,700
| -27% | -$24.6K | 0.01% | 936 |
|
|
2016
Q3 | $143K | Buy |
+6,200
| New | +$143K | 0.02% | 627 |
|